Product
HIPEC
4 clinical trials
6 indications
Indication
Ovarian NeoplasmsIndication
Ovarian CancerIndication
Gallbladder AdenocarcinomaIndication
Ovarian Epithelial Cancer RecurrentIndication
Stomach CancerIndication
MetastaticClinical trial
Phase III Randomized Clinical Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer Considering Two Different Settings: Primary Debulking Surgery (PDS) and Interval Debulking Surgery (IDS)Status: Recruiting, Estimated PCD: 2027-08-01
Clinical trial
Safety and Feasibility of Prophylactic Heated Intra-peritoneal Chemotherapy (HIPEC) for High-Risk Gallbladder AdenocarcinomaStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
A Phase III Randomized Study Evaluating Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in the Treatment of Relapse Ovarian CancerStatus: Active (not recruiting), Estimated PCD: 2023-01-08
Clinical trial
The Efficacy and Safety of HIPEC Combined With PD-1 and SOX Chemotherapy for the Translational Treatment of Gastric or Esophagogastric Junctional Cancer With Peritoneal Metastasis: A Prospective, Multicenter Phase II StudyStatus: Not yet recruiting, Estimated PCD: 2025-05-31